Pediatric Eye Disease Investigator Group (PEDIG)

Protocol: IXT5 - A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Recruiting
Start Date: 12/19/2016
End Date:  
Clinical Trial ID: NCT02807350
Public Dataset:  

 



IXT5 - A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia

 

Protocol

Primary Objective:

  • The objective of this full-scale randomized trial comparing 2.50D overminus lens treatment vs. non-overminus (spectacles without overminus or no spectacles) is to determine the efficacy of overminus lenses after 12 months of treatment.
 


 



Back

© 2007 -2017 Jaeb Center for Health Research
All forms and reports on this site require Adobe Acrobat Reader. Click HERE to download a free copy of Adobe.
Although JCHR supports various web browsers, only Internet Explorer version 11 is fully tested and validated to function on this site.
This site utilizes popup windows.